Active Life: 48 hours
Drug Class: Aromatase inhibitor (Oral)
Average Dose: 0.25 - 1.0 mg/day
Acne: Yes
Water Retention: No
High Blood Pressure: May reduce bp when using aromatizable steroids
Liver Toxic: Yes
Decrease HPTA function: No
Arimidex® (generic name is anastrozole) is a newer drug developed
for the treatment of advanced breast cancer in women. It is manufactured
by Zenica Pharmaceuticals and was approved for use in the United States
at the end of December 1995. Specifically, Arimidex is the first in
a new class of third-generation selective oral aromatase inhibitors..
It acts by blocking the enzyme aromatase, subsequently blocking the
production of estrogen. Since many forms of breast cancer cells are
stimulated by estrogen, it is hoped that by reducing amounts of estrogen
in the body the progression of such a disease can be halted. This
is the basic premise behind Nolvadex, except this drug blocks the
action and not production of estrogen. The effects of Arimidex can
be quite dramatic to say the least. A daily dose of one tablet (1
mg) can produce estrogen suppression greater than 80 % in treated
patients. With the powerful effect this drug has on hormone levels,
it is only to be used (clinically) by post-menopausal women whose
disease has progressed following treatment with Nolvadex (tamoxifen
citrate). Side effects like hot flushes and hair thinning can be present,
and would no doubt be much more severe in pre-menopausal patients.
For the steroid using male athlete, Arimidex shows great potential.
Up to this point, drugs like Nolvadex and Proviron have been our weapons
against excess estrogen. These drugs, especially in combination, do
prove quite effective. But Arimidex appears able to do the job much
more efficiently, and with less hassle. A single tablet daily (1 mg),
the same dose use clinically, seems to be all one needs for an exceptional
effect (some even report excellent results with only 0.25 mg daily).
When used with strong, readily aromatizing androgens such as Dianabol
or testosterone, gynecomastia and water retention can be effectively
blocked. In combination with Propecia (finasteride), we have a great
advance. With the one drug halting estrogen conversion and the other
blocking 5-alpha reduction , related side effects can be effectively
minimized. Here the strong androgen testosterone could theoretically
provide incredible muscular growth, while at the same time being as
tolerable as nandrolone. Additionally the quality of the muscle should
be greater, the athlete appearing harder and much more defined without
holding excess water.
There are some concerns with using an aromatase inhibitor such as
this during prolonged steroid treatment however. While it will effectively
reduce estrogenic side effects, it will also block the beneficial
properties of estrogen from becoming apparent (namely its effect on
cholesterol values). Studies have clearly shown that when an aromatase
inhibitor is used in conjunction with a steroid such as testosterone,
suppression of HDL (good) cholesterol becomes much more pronounced.
Apparently estrogen plays a role in minimizing the negative impact
of steroid use. Since the estrogen receptor antagonist Nolvadex is
shown not to display an anti-estrogenic effect on cholesterol values,
it is certainly the preferred from of estrogen maintenance for those
concerned with cardiovascular health.
Arimidex has another principle drawback, namely the great price of
this drug. Tablets can easily sell for $10 each, becoming quite costly
with regular use. Clearly the price of an ancillary drug can be much
greater than the steroids themselves, a situation destined not to
be popular with recreational bodybuilders. Competitors on the other
hand are likely to welcome this item. It can ward off the side effects
of strong androgen therapy much better than Nolvadex and/or Proviron,
making heavy cycles much more comfortable. As the number of countries
manufacturing this drug increases, we may be able to look forward
to a reduction in price. Privately compounded versions of "liquid
Arimidex" have also been formulated "for research purposes"
are also available. Generic tabs are also available and these two
forms represent a very cost-effective alternative for buying the brand
name drug.